MiR-596 inhibits osteoblastic differentiation and cell proliferation by targeting Smad3 in steroid-induced osteonecrosis of femoral head
Authors:
Open Access
- 14 May 2020
- journal article
- research article
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 15 (1) , 1-10
Abstract
Background: It is reported that miR-596 has a potential diagnostic value for non-traumatic osteonecrosis of the femoral head (NOFH), but its underlying mechanisms in NOFH is unclear. Methods: The expression of miR-596 and Smad3 was detected by western blot and quantitative real-time PCR. The relationship between the two molecules was explored using Dual-Luciferase Reporter Assay. Glucocorticoid (GC)—dexamethasone, was used to induce bone marrow mesenchymal stem cell (BMSC) osteogenic differentiation, and the effects of miR-596 on BMSC osteogenic differentiation and proliferation were determined. Results: MiR-596 expression was upregulated, while Smad3 expression was inhibited in the bone marrow samples of patients with steroid-induced osteonecrosis of femoral head (SANFH). Overexpression of miR-596 inhibited the proliferation and osteogenic differentiation of BMSCs induced by GC. Meanwhile, the opposite results were observed in the miR-596 inhibitor group. In addition, Smad3 was a target gene of miR-596, and negatively regulated by miR-596. The promotion effect of the miR-596 inhibitor on BMSC proliferation and osteogenic differentiation was reversed by si-Smad3. Conclusion: MiR-596 can suppress GC-BMSC osteoblastic differentiation and proliferation by regulating Smad3 expression.Keywords
This publication has 47 references indexed in Scilit:
- Identification of aberrantly expressed of serum microRNAs in patients with hormone-induced non-traumatic osteonecrosis of the femoral headBiomedicine & Pharmacotherapy, 2015
- MicroRNA expression in bone marrow mesenchymal stem cells from mice with steroid-induced osteonecrosis of the femoral headMolecular Medicine Reports, 2015
- Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injectionStem Cell Research & Therapy, 2015
- Increased risk of revision in patients with non-traumatic femoral head necrosisActa Orthopaedica, 2013
- Aberrant CpG Islands’ Hypermethylation of ABCB1 in Mesenchymal Stem Cells of Patients with Steroid-associated OsteonecrosisThe Journal of Rheumatology, 2013
- The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathwayBiological Chemistry, 2012
- microRNAs as novel regulators of stem cell pluripotency and somatic cell reprogrammingBioEssays, 2012
- Smad3-dependent nuclear translocation of β-catenin is required for TGF-β1-induced proliferation of bone marrow-derived adult human mesenchymal stem cellsGenes & Development, 2006
- The Loss of Smad3 Results in a Lower Rate of Bone Formation and Osteopenia Through Dysregulation of Osteoblast Differentiation and ApoptosisJournal of Bone and Mineral Research, 2001
- Caenorhabditis elegans genes sma-2, sma-3, and sma-4 define a conserved family of transforming growth factor beta pathway components.Proceedings of the National Academy of Sciences, 1996